Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copy Number Alterations in CDKN2A/2B and MTAP Genes Are Associated With Low MEF2C Expression in T-cell Acute Lymphoblastic Leukemia. | Cureus | 2022 | 36601176 | PubTator, text mining | PubMed |
| Protein acylation: mechanisms, biological functions and therapeutic targets. | Signal Transduct Target Ther | 2022 | 36577755 | PubTator, text mining | PubMed |
| High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial. | Front Oncol | 2022 | 36568250 | PubTator, text mining | PubMed |
| Compritol-Based Alprazolam Solid Lipid Nanoparticles for Sustained Release of Alprazolam: Preparation by Hot Melt Encapsulation. | Molecules | 2022 | 36558027 | PubTator, text mining | PubMed |
| An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. | Int J Mol Sci | 2022 | 36555852 | PubTator, text mining | PubMed |
| Generation of CD34+CD43+ Hematopoietic Progenitors to Induce Thymocytes from Human Pluripotent Stem Cells. | Cells | 2022 | 36552810 | PubTator, text mining | PubMed |
| Clinical characteristics, pathology features and outcomes of pediatric myeloid sarcoma: A retrospective case series. | Front Pediatr | 2022 | 36545668 | PubTator, text mining | PubMed |
| Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods. | Sci Rep | 2022 | 36543921 | PubTator, text mining | PubMed |
| Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials. | Stem Cell Investig | 2022 | 36540355 | PubTator, text mining | PubMed |
| NUC-7738 regulates β-catenin signalling resulting in reduced proliferation and self-renewal of AML cells. | PLoS One | 2022 | 36520954 | PubTator, text mining | PubMed |
| Primate gastrulation and early organogenesis at single-cell resolution. | Nature | 2022 | 36517595 | PubTator, text mining | PubMed |
| IL-1RAP, a Key Therapeutic Target in Cancer. | Int J Mol Sci | 2022 | 36499246 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value. | Int J Mol Sci | 2022 | 36499220 | PubTator, text mining | PubMed |
| Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. | Cancers (Basel) | 2022 | 36497494 | PubTator, text mining | PubMed |
| Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation. | Cancers (Basel) | 2022 | 36497471 | PubTator, text mining | PubMed |
| EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. | J Exp Clin Cancer Res | 2022 | 36482393 | PubTator, text mining | PubMed |
| SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. | Clin Epigenetics | 2022 | 36461046 | PubTator, text mining | PubMed |
| Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study. | BMC Cancer | 2022 | 36461002 | PubTator, text mining | PubMed |
| Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors. | Front Pharmacol | 2022 | 36457711 | PubTator, text mining | PubMed |
| Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia. | Comput Math Methods Med | 2022 | 36452482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=18